This webinar will be organized to support AIM Members, Academic Pharmacy Section Members, and academic pharmacists from all around the world to plan and get prepared for the new academic year after the educational disruption by COVID-19 pandemic. From Europe to Middle East, different regional perspectives will be offered on reopening of the schools and returning to pharmacy education for the upcoming year. The webinar will support you to start the next academic year resourcefully and resolve different challenges at your institution. The speakers will share their experience and knowledge for the ongoing preparations in their schools, and the participants will be able to ask questions to have institutional solutions for return to pharmacy education. 

Learning objectives:

1. Explore different academic approaches from all around the world on how to plan and prepare for the upcoming academic year,
2. Address the new “must”s for the pharmacy education’s new academic year following COVID-19 related educational disruption,
3. Learn to foster a conscious culture for teaching and learning for the academics and students 

he pandemic has impacted many aspects of our society, including our supply chains. Many drugs became or are becoming short on supply throughout the world.

Supply disruptions and shortages do not only affect final drug products during this pandemic. They can also affect active pharmaceutical ingredients (APIs) and excipients. Medicines affected hence include re-purposed drugs to prevent/treat CoViD-19 as well as routinely used medicines.

With speakers from different regions of the world, this webinar will present some of the medicines supply disruption and shortages, state some of the potential reasons, and introduce actions taken by governments and organisations to face these challenges.
Learning objectives:
● Describe the differences between supply disruptions, low stocks, and shortages
● List the main medicines and healthcare products affected
● Explain the potential impact of these issues
● Outline different strategies developed to face these problems in different regions and countries

Moderator:
Ulf Janzon, President Swedish Pharmacists Association - Sweden

Panellists:
1. Propser Hiag, President African Pharmaceutical Forum - Cameroon
2. Joan Alexis, Sepulveda Mora CEO Chami Business Group - Colombia
3. Joao Ferreira, Scientific Officer European Medicines Agency - the Netherlands
4. J. Jayaseelan Chairman, IPA Industrial Pharmacy Division - India

Facilitator:
Clement Haeck, FIP YPG Drug Delivery and Manufacturing SIG Liaison - France
Gerard Lee See, FIP YPG Industrial Pharmacy Section Liaison - Philippines

The intensive care unit is a critical area of problems related to medication and adverse events to medications. The severity and instability of the patients, together with the high degree of complexity of the medication, increase the appearance of errors in any of the phases of the therapeutic chain. Recognizing the activities that promote the efficacy, safety, and efficiency of pharmacological treatments in critically ill patients promotes the incorporation of the hospital pharmacist into the intensive care healthcare team as an element to support the optimization of pharmacotherapy and the consequent decrease in healthcare costs

Learning objectives: 

• Distinguish the main physiological aspects of a critically ill patient.
• Describe the activities that the pharmacist can carry out as a member of the care team of an intensive care unit.
• Identify the main challenges in the pharmacological management of a critically ill patient.


Organised by the Pharmaceutical Forum of the Americas.

Misinformation regarding vaccines, lack of understanding regarding their important benefits, and limiting fears and beliefs are factors that present challenges to vaccination. The amount of misinformation about vaccines circulating on the Internet in recent years has generated a worrying level of hesitancy or outright opposition to the use of vaccines by growing anti-vaccination groups in many countries. This has been associated with the return or increase of diseases such as measles and whooping cough. Pharmacists play a critical role in building confidence in vaccines and providing evidence-based advice.

Learning Objectives:

After this webinar the participants should have a better understanding of the following topics:

1. (Dis)trust in medicines and vaccines
2. Benefits of vaccines
3. Evidence-based advice through pharmacist
4. Vaccination and quality of life for older adults
5. Engaging with members of the public in a meaningful way
6. How to interact efficiently with patients in a very short time 

As the coronavirus pandemic claims hundreds of thousands of lives across the globe, a parallel crisis of substandard and falsified (SF) medical products claiming to prevent, treat, detect and even cure COVID-19 threatens to add to the growing death toll.

Currently, with no safe and effective vaccine available, a vast window of opportunity has opened for criminals to exploit fearful populations by selling fake coronavirus medicines, IVD test kits, disinfectants, masks and other medical products for significant profit. Drug shortages caused by the crisis have created ideal conditions for SF medical products to fill the gap both online and offline.

In our last FIP digital event on this issue on 18 June 2020, we explored the SF issue through five perspectives: (1) illicit sale of medicines online; (2) country experience of frontline pharmacy in Rwanda; (3) role of education, training & advocacy; (4) role of Pharmaceutical Industry and (5) role of youth leadership.

In this follow up “Part 2”, we continue the discussion with our panelists and dedicate this to address the many questions and comments we received from our June 18 participants and attendees. Please join us to continue this very important discussion and explore additional facets to fight this fight together!

Moderator:
Lina Bader, Lead for Workforce Transformation and Development, FIP - the Netherlands

Panelists:
1. Oksana Pyzik, Senior Teaching Fellow & Global Engagement Lead, UCL School of Pharmacy - UK
2. Maryam Jetha, UCL Fight The Fakes Student Co-Lead, UCL School of Pharmacy - UK
3. Mike Isles, Executive Director of Alliance of Safe Online Pharmacies - UK
4. Flandrie Habyarimana, Founder & President Rwandan Community Pharmacists Union - Rwanda
5. Stanislas Barro, Global Head of Anti-Counterfeiting Norvatis - Switzerland